Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | BNC105P |
Synonyms | |
Therapy Description |
BNC105P is a prodrug that upon intracellular conversion to BNC105 selectively inhibits tubulin polymerization, which potentially interferes with tumor vasculature, and may induce tumor cell necrosis and reduce tumor growth (PMID: 20515948). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
BNC105P | BNC 105P|BNC 105P | BNC105P is a prodrug that upon intracellular conversion to BNC105 selectively inhibits tubulin polymerization, which potentially interferes with tumor vasculature, and may induce tumor cell necrosis and reduce tumor growth (PMID: 20515948). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|